reconciliation currency. Thank I in All numbers numbers growth in Kurt. constant given you, release. GAAP is today The to be will included sales reference our press
the slightly, total slightly. declined For each X.X%. during prior stable, The our fairly of quarter grew the quarter sales year, slightly, to same and July the comparing the performance September August grew month month was grew third XXXX, and
X.X% versus For quarter, increased U.S. year the the quarter. prior full sales the our in
the levels for grew was around the sales from down COVID-XX related Geographies and international the globe digits America responses. full the government grew low-single varying Europe experiencing X.X% and the quarter significantly. decreased mid-single down digits, compared digits, was to the of year. overall, impact Asia in Latin Canada are Our in prior single
Internationally the impacts in orthopedics third declined the decreased about it orthopedic most decreased U.S. challenges internationally the the third we digits Latin in were sales general virus products world grew as and third focused the Filter X.X%. worldwide America in revenue X.X% general quarter. use down sales Total general hospitals quarter, in remained the the likely revenue increased digits future XX.X%. safety. X.X%. and globally. the operating rooms U.S. see the how Worldwide U.S. surgery the improving on in the in strong Capital X.X% and uncertainty revenue and of double growth around grew In mid-single orthopedic Worldwide the sales Buffalo surgery decreased in surgery is persistent. Orthopedics as both quarter. While the sales orthopedic global, single AirSeal X.X% in revenue quarter.
to move income let's Now the the side statement. expense of
special XX.X%, quarter increase from integrations, an assets, which basis quarter. for prior margin of tax. expenses will net manufacturing deferred discount and charges and related Adjusted acquisitions the financing intangible We XX gross to excluding and discuss of points items, and amortization of restructurings, consolidations, of debt fees profitability, include was year the third amortization
Our offset In improvement product recognition here as the underlying expect and margin manufacturing improvement channel we unfavorable expected. of variances. mix of timing gross by we is driving QX,
We recognized expect those these in in worse variances than of to XXXX. QX, XXXX, about $X QX be million
look difficult total year total year was get So development may similar the point margin basis Research period. should expenses But are our the decrease obvious to improvements once XX for quarter. through gross the we underlying prior sales, of X.X% from QX the and quarter quarter. and a this prior be meaningful third
of a R&D While higher QX, light anticipate little the spend in was levels spend R&D in QX. we
in strong basis were our basis by sales, of we've the challenges Third Tax to over decrease expense on an XXXX XXX very expense QX moved pandemic by and XX.X% basis. volatile Interest we losses basis adjusted improved a points QX margin adjusted million QX quarter was has presented QX been the XXX from from SG&A an controls on pandemic, points in as pretty to XXXX. XXXX. $X.X of operating expenses despite profitability adjusted the QX. this strong in rate through Due
tax as the tax around rate we that provision the the in elevated of foreign QX, rate lower For is for reason, new updated GAAP is details handling the and income. tax adjusted guidance
flat $X.XX quarter Third totaled million to or $X.X share, net diluted the year income per quarter. was prior GAAP which
items earlier impact $XX.X the third in of reported XXXX. to million, net compared we special quarter million adjusted income the of Excluding $XX.X discussed of
XX% per increase was the quarter prior Our $X.XX, net year share diluted adjusted earnings an third period. of over
at XXX of QX days was end the of at the and of days to Turning the June end And of to quarter days versus second compared end of XX, Long-term end June were the million quarter. XX as the $XXX to of days Inventory cash $XX.X Accounts the of end compared the quarter XXXX. sheet, second quarter, was compared XX of as as were XXXX. the $XX.X XX XXX end to at end balance $XXX debt days days million of compared at quarter XX, the XXXX. compared at at million, XX. at the million QX XXX to days receivable the balance to September our
quarter prior was leverage at times, XXXX XX Our our decrease the well original X.X good ratio a from within September covenants. and
banks. performing agreement We very to amended favorably the are our with
$XX.X charge compared in at September $X.X coverage agreement million to provided third million. X.XX Capital quarter. million the of versus XX X.X is flow $XXX to the quarter $XXX and quarter for agreement from were compared compared our the in the Cash year expenditures our of liquidity million, minimum operations quarter fixed of $XX.X million to was in third Our $X.X XXXX. million prior is our
increased pandemic, return, focused our to this best share over market profitability generation. partner be and We to the our on term. continued improved that rewarded control the by have cash will sales being we as during led with strong remaining expense to So believe ongoing flow disciplined long possible has customers
call the appropriate back time. open continued we'd to the guidance I'll not given ongoing it hand created pandemic, like at the we global it to And Lastly, questions, without do issue feel uncertainty and this to your to by Crystal.